Report Detail

Other Global Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025

  • RnM3325638
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Sulfonylureas
      • 1.4.3 Meglitinides
      • 1.4.4 Biguanides
      • 1.4.5 Thiazolidinediones
      • 1.4.6 Alpha-glucosidase Inhibitors
    • 1.5 Market by Application
      • 1.5.1 Global Oral Antidiabetic Agents Market Share by Application (2014-2025)
      • 1.5.2 Home Use
      • 1.5.3 Medical Institutions
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Oral Antidiabetic Agents Market Size
    • 2.2 Oral Antidiabetic Agents Growth Trends by Regions
      • 2.2.1 Oral Antidiabetic Agents Market Size by Regions (2014-2025)
      • 2.2.2 Oral Antidiabetic Agents Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Oral Antidiabetic Agents Market Size by Manufacturers
      • 3.1.1 Global Oral Antidiabetic Agents Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oral Antidiabetic Agents Key Players Head office and Area Served
    • 3.3 Key Players Oral Antidiabetic Agents Product/Solution/Service
    • 3.4 Date of Enter into Oral Antidiabetic Agents Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Oral Antidiabetic Agents Market Size by Type (2014-2019)
    • 4.2 Global Oral Antidiabetic Agents Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Oral Antidiabetic Agents Market Size (2014-2019)
    • 5.2 Oral Antidiabetic Agents Key Players in United States
    • 5.3 United States Oral Antidiabetic Agents Market Size by Type
    • 5.4 United States Oral Antidiabetic Agents Market Size by Application

    6 Europe

    • 6.1 Europe Oral Antidiabetic Agents Market Size (2014-2019)
    • 6.2 Oral Antidiabetic Agents Key Players in Europe
    • 6.3 Europe Oral Antidiabetic Agents Market Size by Type
    • 6.4 Europe Oral Antidiabetic Agents Market Size by Application

    7 China

    • 7.1 China Oral Antidiabetic Agents Market Size (2014-2019)
    • 7.2 Oral Antidiabetic Agents Key Players in China
    • 7.3 China Oral Antidiabetic Agents Market Size by Type
    • 7.4 China Oral Antidiabetic Agents Market Size by Application

    8 Japan

    • 8.1 Japan Oral Antidiabetic Agents Market Size (2014-2019)
    • 8.2 Oral Antidiabetic Agents Key Players in Japan
    • 8.3 Japan Oral Antidiabetic Agents Market Size by Type
    • 8.4 Japan Oral Antidiabetic Agents Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Oral Antidiabetic Agents Market Size (2014-2019)
    • 9.2 Oral Antidiabetic Agents Key Players in Southeast Asia
    • 9.3 Southeast Asia Oral Antidiabetic Agents Market Size by Type
    • 9.4 Southeast Asia Oral Antidiabetic Agents Market Size by Application

    10 India

    • 10.1 India Oral Antidiabetic Agents Market Size (2014-2019)
    • 10.2 Oral Antidiabetic Agents Key Players in India
    • 10.3 India Oral Antidiabetic Agents Market Size by Type
    • 10.4 India Oral Antidiabetic Agents Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Oral Antidiabetic Agents Market Size (2014-2019)
    • 11.2 Oral Antidiabetic Agents Key Players in Central & South America
    • 11.3 Central & South America Oral Antidiabetic Agents Market Size by Type
    • 11.4 Central & South America Oral Antidiabetic Agents Market Size by Application

    12 International Players Profiles

    • 12.1 Novo Nordisk
      • 12.1.1 Novo Nordisk Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Oral Antidiabetic Agents Introduction
      • 12.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.1.5 Novo Nordisk Recent Development
    • 12.2 Eli Lilly
      • 12.2.1 Eli Lilly Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Oral Antidiabetic Agents Introduction
      • 12.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.2.5 Eli Lilly Recent Development
    • 12.3 Sanofi
      • 12.3.1 Sanofi Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Oral Antidiabetic Agents Introduction
      • 12.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.3.5 Sanofi Recent Development
    • 12.4 Roche
      • 12.4.1 Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Oral Antidiabetic Agents Introduction
      • 12.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.4.5 Roche Recent Development
    • 12.5 Teva
      • 12.5.1 Teva Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Oral Antidiabetic Agents Introduction
      • 12.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.5.5 Teva Recent Development
    • 12.6 AstraZeneca
      • 12.6.1 AstraZeneca Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Oral Antidiabetic Agents Introduction
      • 12.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.6.5 AstraZeneca Recent Development
    • 12.7 Wockhardt UK
      • 12.7.1 Wockhardt UK Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Oral Antidiabetic Agents Introduction
      • 12.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.7.5 Wockhardt UK Recent Development
    • 12.8 Merck
      • 12.8.1 Merck Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Oral Antidiabetic Agents Introduction
      • 12.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.8.5 Merck Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Oral Antidiabetic Agents Introduction
      • 12.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Cipla
      • 12.10.1 Cipla Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Oral Antidiabetic Agents Introduction
      • 12.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2014-2019)
      • 12.10.5 Cipla Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
      In 2018, the global Oral Antidiabetic Agents market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Antidiabetic Agents development in United States, Europe and China.

      The key players covered in this study
      Novo Nordisk
      Eli Lilly
      Sanofi
      Roche
      Teva
      AstraZeneca
      Wockhardt UK
      Merck
      Pfizer
      Cipla

      Market segment by Type, the product can be split into
      Sulfonylureas
      Meglitinides
      Biguanides
      Thiazolidinediones
      Alpha-glucosidase Inhibitors

      Market segment by Application, split into
      Home Use
      Medical Institutions
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players.
      To present the Oral Antidiabetic Agents development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Oral Antidiabetic Agents are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025. Industry analysis & Market Report on Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025 is a syndicated market report, published as Global Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Oral Antidiabetic Agents Market Size, Status and Forecast 2019-2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,804.10
      4,206.15
      5,608.20
      3,272.10
      4,908.15
      6,544.20
      431,418.00
      647,127.00
      862,836.00
      289,536.00
      434,304.00
      579,072.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report